| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07540364 | A Phase 3 Study to Evaluate the Efficacy and Safety of Samelisant in Patients With… | Narcolepsy | Recruiting | 2026-09-03 |
| NCT05397639 | Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type | Agitation | Active, Not Recruiting | 2026-09-15 |
Alzheimer's Disease (1) · Dementia (1)